HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia

Human Immunology

Volumn 68, Issue 10, 2007, Pages 849-853

  Tamouza, Ryad ^a   Busson, Marc ^a   Fortier, Catherine ^a   Diagne, Ibrahima ^b   Diallo, Dapa ^c   Sloma, Ivan ^a   Contouris, Hector ^a   Krishnamoorthy, Rajagopal ^d   Labie, Dominique ^e   Girot, Robert ^f   Charron, Dominique ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Albert Royer Hospital   (Senegal)

^c UNIVERSITY OF BAMAKO   (Mali)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e INSTITUT COCHIN   (France)

^f HÔPITAL TENON   (France)

Author keywords

Bacterial infections; HLA E polymorphism; Sickle cell anemia

Indexed keywords

HLA E ANTIGEN; HLA ANTIGEN; HLA E*0101 ANTIGEN; HLA-E*0101 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AFRICA; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATHOGENESIS; POLYMORPHIC LOCUS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; ALLELE; COMORBIDITY; FRANCE; GENETICS; HOMOZYGOTE; MALI; MICROBIOLOGY; NEGRO; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SENEGAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ANEMIA, SICKLE CELL; BACTERIAL INFECTIONS; COMORBIDITY; FEMALE; HLA ANTIGENS; HOMOZYGOTE; HUMANS; MALE; MALI; PARIS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SENEGAL;

EID: 35348987704     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.08.260     Document Type: Article

References (21)

1. Serjeant G.R. The clinical features of sickle cell disease. In: Higgs D.R., and Weatherall D.J. (Eds). Bailliere's Clinical Haematology: The Haemoglobinopathies (1993), Bailliere Tindall 93
2. Serjeant G.R., and Serjeant B.E. The immune system. In: Serjeant G.R., and Serjeant B.E. (Eds). Sickle Cell Disease. Third Edition (2001), Oxford University Press 170
3. Tamouza R., Neonato M.G., Busson M., Marzais F., Girot R., Labie D., et al. Infectious complications in sickle cell disease are influenced by HLA class II alleles. Hum Immunol 63 (2002) 194
4. Costa R.N., Conran N., Albuquerque D.M., Soares P.H., Saad S.T., and Costa F.F. Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia. Haematologica 90 (2005) 977
5. Braud V.M., Allan D.S., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391 (1998) 795
6. Tomasec P., Braud V.M., Rickards C., Powell M.B., McSharry B.P., Gadola S., et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287 (2000) 10311
7. International ImMunoGeneTics. IMGT/HLA Sequence Database (2007). http://www.ebi.ac.uk/imgt/hla/ Available at: http://www.ebi.ac.uk/imgt/hla/. Last accessed July
8. Ulbrecht M., Couturier A., Martinozzi S., Pla M., Srivastava R., Peterson P.A., and Weiss E.H. Cell surface expression of HLA-E: Interaction with human beta2-microglobulin and allelic differences. Eur J Immunol 29 (1999) 537
9. Strong R.K., Holmes M.A., Li P., Braun L., Lee N., and Geraghty D.E. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 278 (2003) 5082
10. Tripathi P., Naik S., and Agrawal S. HLA-E and immunobiology of pregnancy. Tissue Antigens 67 (2006) 207
11. Lajoie J., Hargrove J., Zijenah L.S., Humphrey J.H., Ward B.J., and Roger M. Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J Infect Dis 193 (2006) 298
12. Hirankarn N., Kimkong I., and Mutirangura A. HLA-E polymorphism in patients with nasopharyngeal carcinoma. Tissue Antigens 1= 64 (2004) 588
13. Tamouza R., Rocha V., Busson M., Fortier C., El Sherbini S.M., Esperou H., et al. Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation. Transplantation 80 (2005) 140
14. Gomez-Casado E., Martinez-Laso J., Vargas-Alarcon G., Varela P., Diaz-Campos N., Alvarez M., et al. Description of a new HLA-E (E*01031) allele and its frequency in the Spanish population. Hum Immunol 54 (1997) 69
15. Arnaiz-Villena A., Vargas-Alarcon G., Serrano-Vela J.I., Reguera R., Martinez-Laso J., Silvera-Redondo C., et al. HLA-E polymorphism in Amerindians from Mexico (Mazatecans), Colombia (Wayu) and Chile (Mapuches): Evolution of MHC-E gene. Tissue Antigens 69 Suppl 1 (2007) 132
16. Matte C., Lacaille J., Zijenah L., Ward B., Roger M., and The ZVITAMBO Study Group. HLA-G and HLA-E polymorphisms in an indigenous African population. Hum Immunol 61 (2000) 1150
17. Ulbrecht M., Modrow S., Srivastava R., Peterson P.A., and Weiss E.H. Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation. J Immunol 160 (1998) 4375
18. Heinzel A.S., Grotzke J.E., Lines R.A., Lewinsohn D.A., McNabb A.L., Streblow D.N., et al. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J Exp Med 196 (2002) 1473
19. Lo W.F., Ong H., Metcalf E.S., and Soloski M.J. T cell responses to gram-negative intracellular bacterial pathogens: A role for CD8+ T cells in immunity to salmonella infection and the involvement of MHC class Ib molecules. J Immunol 162 (1999) 5398
20. Seaman M.S., Wang C.R., and Forman J. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J Immunol 165 (2000) 5192
21. Rolph M.S., Raupach B., Kobernick H.H., Collins H.L., Perarnau B., Lemonnier F.A., and Kaufmann S.H. MHC class Ia-restricted T cells partially account for beta2-microglobulin-dependent resistance to Mycobacterium tuberculosis. Eur J Immunol 31 (2001) 1944